Google+ Google+

Actos Recall is Overdue: Reasons It’s Time For An Actos Recall in the U.S

The diabetes drug Actos was recalled in France and Germany in June 2011 because studies showed it increased patients’ risks of developing bladder cancer and congestive heart failure. But instead of requesting an Actos recall n the U.S., the FDA merely issued a warning about the risk of bladder cancer.

In the time since France and Germany recalled Actos, there have been two new studies confirming the bladder cancer risk (June 1, 2012 and July 3, 2012). There has also been a study (June 11, 2012) showing that Actos increases the risk of macular edema, which causes blurred vision.

Actos bladder cancer victims have filed so many lawsuits that the federal lawsuits have been consolidated in Actos Multidistrict litigation. Both California and Illinois have a number of consolidated Actos lawsuits filed in their state courts.

According to an Associated Press article, Takeda Pharmaceutical Co., Ltd. (“Takeda”), the maker of Actos, took in $3.4 billion in sales of Actos in the U.S. in 2011. Pardon me if I wonder if the maker of Acts cares more about profits that it does the health of people with diabetes.

Money in medicine bottles.To try to build public support for an Actos recall, I’ve created a Recall Actos Facebook Page, a Recall Actos Google+ Page, a RecallActos Twitter account, and a RecallActos.com website where people can sign a petition calling for a recall.

I’ve also created a website where Actos patients who developed bladder cancer (and their family members) can get information and obtain a free legal evaluation of their potential Actos lawsuit.

The Actos lawsuit website includes shocking excerpts from an Actos whistleblower lawsuit filed by a former medical researcher for Takeda. The website also offers people with bladder cancer (and their family members) the opportunity to obtain a free Actos lawsuit review by calling 800-671-0996 toll free, 24 hours a day, 7 days a week or using the website’s Free Actos Lawsuit Review Form.

_____

If you take Actos, you should continue taking it until you can schedule an appointment to discuss the drug’s risks with your doctor. And between now and your appointment, do some research on the risks of the drug. A good place to begin your research is the Actos Lawsuit Background post at Actos-Lawsuit.pro. That post gives a good history of the regulatory background and the studies regarding Actos and bladder cancer.

Actos® is one of the trade names under which the drug pioglitazone is marketed. ACTOS, ACTOplus met, ACTOplus met XR, and Duetact are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals U.S.A., Inc.

Actos Recall Time?

I believe it’s time for an online campaign, including social media, to educate the public and push for a recall of the diabetes drug Actos®.

Actos was recalled in France and Germany in 2011 because of the risks of bladder cancer and congestive heart failure. The FDA, instead of recalling Actos, merely issued a warning.

Now two studies in June and July 2012 have confirmed the risk of bladder cancer, and another study in June 2012 shows that Actos increases the risk of macular edema, which causes blurred vision.

The Actos situation today reminds me of the Rezulin debacle in 2000. Rezulin, a diabetes drug with huge sales, was causing liver failure in some patients taking the drug.

At the time, Dr. Sidney Wolfe of Public Citizen’s Health Research Group had called on the FDA to recall Rezulin, but the FDA was slow to act., The drug company was denying the problems and fighting all recall efforts. Meanwhile, some patients taking Rezulin died and others had liver transplants.

I joined with a group of law firms to create what we called “The Rezulin Legal Alliance.” We put up two websites laying out the case for recalling Rezulin. And we offered to represent patients with liver damage due to the drug.

Eventually, Rezulin was recalled, and the Rezulin Legal Alliance law firms represented over 1,000 Rezulin victims with liver damage in successful litigation against the maker of the drug.

The Actos situation today reminds me very much of the Rezulin debacle. The maker of Actos is ignoring the problem, and the FDA has been slow to act. As in the case of Rezulin, we know the opinion of consumer advocate Dr. Sidney Wolfe. Actos has long been on his list of pills to avoid because he says there are safer alternatives available, such as metformin (Glucophage) and glipizide (Glucotrol).

The evidence against Actos keeps accumulating, yet the drug maker and the FDA have not recalled Actos. People who are concerned about the issue need to call on them to recall Actos.

_____

Patients taking Actos should not stop taking it before consulting with their physician. Before meeting with your doctor, you may want to research the issue of the safety of Actos. I’ve posted links to some of the relevant articles below.

Actos® is one of the trade names under which the drug pioglitazone is marketed. ACTOS, ACTOplus met, ACTOplus met XR, and Duetact are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals U.S.A., Inc.

Attorney Advertising

No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. The hiring of a law firm is a serious decision that should not be based on advertising alone.